Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Schizophrenia Research|September 15, 2020
Hostility and aggressive behaviour in first episode psychosis: Results from the OPTiMiSE trialMargo D M Faay, G Caroline M van Baal, Celso Arango, et al.
The Journal of Clinical Psychiatry|July 4, 2009
Intervention in individuals at ultra-high risk for psychosis: a review and future directionsPatrick D McGorry, Barnaby Nelson, G Paul Amminger, et al.
Early Intervention in Psychiatry|August 18, 2015
NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disordersConnie Markulev, Patrick D McGorry, Barnaby Nelson, et al.
JAMA Network Open|January 2, 2026
ω-3 Fatty Acids in Pediatric Major Depressive Disorder: A Randomized Clinical TrialGregor Berger, Isabelle Häberling, Sophie Emery, et al.
The Australian and New Zealand Journal of Psychiatry|August 26, 2025
Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO studyMonika Schlögelhofer, Ashleigh Lin, Connie Markulev, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Schizophrenia Bulletin|October 25, 2024
Effectiveness of Omega-3 Fatty Acids Versus Placebo in Subjects at Ultra-High Risk for Psychosis: The PURPOSE Randomized Clinical TrialInge Winter-van Rossum, Margot I E Slot, Hendrika H van Hell, et al.
Schizophrenia Bulletin|December 20, 2024
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk IndividualsCassandra Wannan, Isabelle Scott, Dominic Dwyer, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 16, 2024
Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra-high risk in the UHR 1000+ cohortSimon Hartmann, Dominic Dwyer, Blake Cavve, et al.
Schizophrenia Bulletin|January 20, 2024
Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development StudyJonah F Byrne, Colm Healy, Melanie Föcking, et al.
Pageof 7